Author

N. Peinovich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:differential expression· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Organism:non-human primate· 1

Frequent Co-Authors

E. G. Dora· 3 shared C. I. Martinez· 2 shared M. Cortese· 2 shared S. N. Tedjakusuma· 2 shared S. N. Tucker· 2 shared A. C. Moore· 1 shared A. Werts· 1 shared B. A. Flitter· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

E. G. Dora

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mucosal Immunization of Cynomolgus Macaques with Adenoviral Vector Vaccine Elicits Neutralizing Nasal and Serum Antibody to Several SARS-CoV-2 Variants

B. A. Flitter, C. A. Lester, S. N. Tedjakusuma, E. G. Dora, N. Peinovich, M. Cortese, C. I. Martinez, C. B. Jegede, E. D. Neuhaus, S. N. Tucker

This study evaluates mucosal immunization with SARS-CoV-2 adenoviral vaccines in macaques, finding that a Wuhan-specific vaccine induces strong cross-reactive serum and nasal antibody responses against multiple variants.

bioRxiv · Feb 21, 2022 · PreprintImmunology

Oral and intranasal Ad5 SARS-CoV-2 vaccines decrease disease and viral transmission in a golden hamster model

S. N. Langel, S. Johnson, C. I. Martinez, S. N. Tedjakusuma, N. Peinovich, E. G. Dora, P. J. Kuehl, H. Irshad, E. G. Barrett, A. Werts, S. N. Tucker

This study shows oral and intranasal Ad5 SARS-CoV-2 vaccines reduce disease severity and viral transmission in golden hamsters.

bioRxiv · Oct 3, 2021Immunology

Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection

A. C. Moore, E. G. Dora, N. Peinovich, K. P. Tucker, K. Lin, M. Cortese, S. Tucker

This study evaluates mucosal adenovirus vaccines against SARS-CoV-2, showing that full-length spike antigen induces stronger neutralizing antibodies and T-cell responses compared to partial antigens in mice.

bioRxiv · Sep 4, 2020 · PreprintImmunology